Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression
Article Abstract:
A study was conducted among Koreans with late-life depression to determine whether antidepressant responses to selective serotonin reuptake inhibitors (SSRIs) or norepinephrine reuptake inhibitors (NRIs) are associated with genetic polymorphisms of the corresponding monoamine transporters. Results suggested that monoamine transporter gene polymorphisms are associated with response to antidepressants with homologous monoamine transporter targets, thus enabling refined pharmacogenetic selection of antidepression treatment.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial
Article Abstract:
A study to ascertain the effectiveness of using behavioral treatment along with venlafaxine for adolescents with continued depression not responding to treatment with selective serotonin reuptake inhibitor (SSRI) is conducted. Results reveal that the combined therapy yielded improved results and a change to another SSRI produced the same results as when using venlafaxine.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials
Article Abstract:
The efficacy and risk of reported suicidal ideation/suicide attempt of antidepressants for treatment of pediatric major depressive disorder (MDD), obsessive-compulsive disorder (OCD) and non-OCD) anxiety disorders are assessed. The results have shown that the effects are strongest in non-OCD anxiety disorders, intermediate in OCD and more modest in MDD.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Effectiveness of adjunctive antidepressant treatment for bipolar depression. Medication augmentation after the failure of SSRIs for depression
- Abstracts: Taking a stand against falls. Speaking out for women with postnatal depression. Caliber of conduct case judges ' very variable'
- Abstracts: The antidepressant quandary--Considering suicide risk when treating adolescent depression. What ails the FDA?
- Abstracts: Recognize the many facets of gerontological nursing. Ground instability with mentoring
- Abstracts: 'The program portrays nursing as an endless string of isolated manual tasks'. Patients may delay going to A&E for fear of being made to have an HIV test